Risk factors and prophylaxis against invasive fungal disease for haematology and stem cell transplant recipients: an evolving field.

Abstract:

INTRODUCTION:Due to increasing intensity and complexity of therapies and longer survivorship, many patients with haematologic malignancy (HM) are at risk of invasive fungal disease (IFD). Mortality from IFD is high and treatment of an episode of IFD results in an excess length of hospital stay and costs and delays delivery of curative therapy of the underlying haematologic condition. Therefore, prevention and early recognition and treatment of IFD are crucial. Areas covered: Risk factors particular to certain HMs and haematopoietic stem cell transplantation, as well as those risk factors universal to all HM groups are examined. Expert commentary: Risk stratification identifies those patients who would benefit most from mould active versus yeast active prophylaxis and those who can be safely managed with monitoring and clinically driven interventions for IFD. This approach aids in antifungal stewardship.

authors

Douglas AP,Slavin MA

doi

10.1080/14787210.2016.1245613

subject

Has Abstract

pub_date

2016-12-01 00:00:00

pages

1165-1177

issue

12

eissn

1478-7210

issn

1744-8336

journal_volume

14

pub_type

杂志文章,评审
  • Extended or continuous versus short-term intravenous infusion of cephalosporins: a meta-analysis.

    abstract::The authors sought to study whether extended or continuous infusion of cephalosporins is associated with better clinical outcomes than short-term infusion. PubMed and Scopus databases were systematically searched. Studies reporting the clinical outcomes of patients receiving extended or continuous infusion (≥3 or 24 h...

    journal_title:Expert review of anti-infective therapy

    pub_type: 杂志文章,meta分析

    doi:10.1586/eri.13.44

    authors: Korbila IP,Tansarli GS,Karageorgopoulos DE,Vardakas KZ,Falagas ME

    更新日期:2013-06-01 00:00:00

  • Is there really no benefit to combination therapy with colistin?

    abstract::Despite many theoretical and in vitro advantages, clinical data comparing combination therapy with colistin + rifampicin to colistin alone for infection due to extremely-drug resistant (XDR) Acinetobacter baumanni are scarce and limited by small numbers and/or low quality evidence. This article represents the first la...

    journal_title:Expert review of anti-infective therapy

    pub_type: 评论,杂志文章

    doi:10.1586/14787210.2013.827881

    authors: Pogue JM,Kaye KS

    更新日期:2013-09-01 00:00:00

  • Current research toward optimizing dosing of first-line antituberculosis treatment.

    abstract:INTRODUCTION:Drug concentrations in tuberculosis patients on standard regimens vary widely with clinically important consequences. Areas covered: We review the available literature identifying factors correlated with pharmacokinetic variability of antituberculosis drugs. Based on population pharmacokinetic models and t...

    journal_title:Expert review of anti-infective therapy

    pub_type: 杂志文章,评审

    doi:10.1080/14787210.2019.1555031

    authors: McIlleron H,Chirehwa MT

    更新日期:2019-01-01 00:00:00

  • Targeting eicosanoid pathways in the development of novel anti-influenza drugs.

    abstract::The constant new emergence of life-threatening human respiratory viral pathogens presents new challenges to clinicians who are left with no available therapeutic interventions. Highly pathogenic strains of influenza A virus (IAV) share an enhanced capacity to propagate to the lower airways and paralyze alveolar macrop...

    journal_title:Expert review of anti-infective therapy

    pub_type: 杂志文章,评审

    doi:10.1586/14787210.2014.966082

    authors: Coulombe F,Divangahi M

    更新日期:2014-11-01 00:00:00

  • Malaria in pregnancy: diagnosing infection and identifying fetal risk.

    abstract::Despite increased malaria control efforts, recent reports indicate that over 1.2 million deaths due to malaria occurred in 2010. Pregnant women represent a particularly vulnerable risk group as malaria infection can lead to life-threatening disease for the mother and fetus. With 125 million women at risk of malaria in...

    journal_title:Expert review of anti-infective therapy

    pub_type: 杂志文章,评审

    doi:10.1586/eri.12.123

    authors: Conroy AL,McDonald CR,Kain KC

    更新日期:2012-11-01 00:00:00

  • Diagnostic accuracy of the Xpert MTB/RIF assay for abdominal tuberculosis: a systematic review and meta-analysis.

    abstract:BACKGROUND:We performed a meta-analysis to determine diagnostic accuracy of Xpert MTB/RIF for diagnosis of abdominal (intestinal or peritoneal) tuberculosis (TB) in various tissues (intestinal, omental/peritoneal tissue or ascitic fluid). METHODS:Electronic databases were searched for observational studies on use of X...

    journal_title:Expert review of anti-infective therapy

    pub_type: 杂志文章

    doi:10.1080/14787210.2020.1816169

    authors: Sharma V,Soni H,Kumar-M P,Dawra S,Mishra S,Mandavdhare HS,Singh H,Dutta U

    更新日期:2020-08-26 00:00:00

  • Detection and diagnosis of Mycobacterium tuberculosis.

    abstract::Tuberculosis continues to be a major health problem worldwide, affecting millions of people each year. Accurate and rapid diagnosis is key to controlling the disease, yet the traditional tests for TB produce results that are either inaccurate or take too long to be definitive. A fast and reliable diagnostic method tha...

    journal_title:Expert review of anti-infective therapy

    pub_type: 杂志文章,评审

    doi:10.1586/eri.09.92

    authors: Al-Zamel FA

    更新日期:2009-11-01 00:00:00

  • New targets in the search for preventive and therapeutic agents for botulism.

    abstract::Botulism is a severe neuroparalytic disease resulting from exposure to one of the most poisonous toxins to humans. Because of this high potency and the use of toxins as biological weapons, botulism is a public health concern and each case represents an emergency. Current therapy involves respiratory supportive care an...

    journal_title:Expert review of anti-infective therapy

    pub_type: 杂志文章,评审

    doi:10.1586/14787210.2014.945917

    authors: Anniballi F,Lonati D,Fiore A,Auricchio B,De Medici D,Locatelli CA

    更新日期:2014-09-01 00:00:00

  • Antibody response to Salmonella: its induction and role in protection against avian enteric salmonellosis.

    abstract::Human enteritis resulting from the consumption of poultry products contaminated with serovars of Salmonella enterica remains a major public-health concern. Reducing food contamination by preventing or controlling infection in the chicken during rearing is an attractive solution. An accurate understanding of the mechan...

    journal_title:Expert review of anti-infective therapy

    pub_type: 杂志文章,评审

    doi:10.1586/14787210.5.5.873

    authors: Beal RK,Smith AL

    更新日期:2007-10-01 00:00:00

  • Predicting bacteremia by procalcitonin levels in patients evaluated for sepsis in the emergency department.

    abstract::Evaluation of: Riedel S, Melendez JH, An AT, Rosenbaum JE, Zenilman JM. Procalcitonin as a marker for the detection of bacteremia and sepsis in the emergency department. Am. J. Clin. Pathol. 135(2), 182-189 (2011). In a recent report, Riedel et al. proposed a procalcitonin cutoff of 0.1 ng/ml to rule out bacteremia in...

    journal_title:Expert review of anti-infective therapy

    pub_type: 评论,杂志文章

    doi:10.1586/eri.11.42

    authors: Albrich WC,Mueller B

    更新日期:2011-06-01 00:00:00

  • Human cytomegalovirus encoded microRNAs: hitting targets.

    abstract::Human cytomegalovirus (HCMV) infection is of particular concern in immunodeficient individuals notably transplant recipients, leading to increased morbidity and mortality. HCMV is predicted to encode multiple microRNAs (miRNAs) and several have been characterized in vitro. Furthermore, these miRNAs have been shown to ...

    journal_title:Expert review of anti-infective therapy

    pub_type: 杂志文章,评审

    doi:10.1586/14787210.2015.1106939

    authors: Ng KR,Li JY,Gleadle JM

    更新日期:2015-01-01 00:00:00

  • HIV care and treatment for children in resource-limited settings.

    abstract::Although efforts to combat the HIV epidemic have focused on the perinatal reduction of HIV transmission, many children are still being infected with HIV in resource-limited settings. Access to HIV care, cotrimoxazole and antiretroviral therapy (ART) for HIV-infected children has greatly improved in recent years, and h...

    journal_title:Expert review of anti-infective therapy

    pub_type: 杂志文章

    doi:10.1586/14787210.6.2.181

    authors: Callens SF,McKellar MS,Colebunders R

    更新日期:2008-04-01 00:00:00

  • The spread and acquisition of NDM-1: a multifactorial problem.

    abstract::bla NDM is a major mechanism of resistance of Gram-negative bacteria to β-lactam antibiotics including the carbapenems. bla NDM has been acquired by a large range of Gram-negative bacilli, especially by the Enterobacteriaceae and Acinetobacter spp. The combination of human factors (suboptimal antibiotic stewardship an...

    journal_title:Expert review of anti-infective therapy

    pub_type: 杂志文章,评审

    doi:10.1586/14787210.2014.856756

    authors: Wailan AM,Paterson DL

    更新日期:2014-01-01 00:00:00

  • Antibiotic prophylaxis in colorectal surgery.

    abstract::Nosocomial infections are the most frequent complications observed in surgical patients. In colorectal surgery, the opening of the viscera causes the dissemination into the operative field of microorganisms originating from endogenous sources, increasing the chance of developing postoperative complications. It is repo...

    journal_title:Expert review of anti-infective therapy

    pub_type: 杂志文章,评审

    doi:10.1586/14787210.3.5.787

    authors: Rovera F,Diurni M,Dionigi G,Boni L,Ferrari A,Carcano G,Dionigi R

    更新日期:2005-10-01 00:00:00

  • Invasive pulmonary aspergillosis.

    abstract::In susceptible patients, invasive aspergillosis has a high incidence and a mortality of up to 80%. The diagnosis of this condition is difficult, especially in the early stages of the disease and, as a consequence, antifungal therapy, despite its expense and toxicity, is often initiated empirically. Until recently, the...

    journal_title:Expert review of anti-infective therapy

    pub_type: 杂志文章,评审

    doi:10.1586/14787210.3.4.613

    authors: Doffman SR,Agrawal SG,Brown JS

    更新日期:2005-08-01 00:00:00

  • Potential of acyclic nucleoside phosphonates in the treatment of DNA virus and retrovirus infections.

    abstract::The acyclic nucleoside phosphonates [HPMPC: cidofovir, Vistide; PMEA: adefovir dipivoxil, Hepsera; and PMPA: tenofovir, Viread] have proven to be effective in vitro (cell culture systems) and in vivo (animal models and clinical studies) against a wide variety of DNA virus and retrovirus infections, for example, cidofo...

    journal_title:Expert review of anti-infective therapy

    pub_type: 杂志文章,评审

    doi:10.1586/14787210.1.1.21

    authors: De Clercq E

    更新日期:2003-06-01 00:00:00

  • Risk factors for West Nile virus infection and disease in populations and individuals.

    abstract::West Nile virus (WNV) is a mosquito-borne enveloped positive-strand RNA virus that emerged in North America in 1999 in New York City. Over the past 15 years, WNV has become established throughout the USA and has spread into Canada, Mexico and the Caribbean. CDC reports indicate >41,000 clinical cases, including more t...

    journal_title:Expert review of anti-infective therapy

    pub_type: 杂志文章,评审

    doi:10.1586/14787210.2015.1007043

    authors: Montgomery RR,Murray KO

    更新日期:2015-03-01 00:00:00

  • Drug combinations for HIV: what's new?

    abstract::Since the advent of combined antiretroviral therapy there have been reductions in mortality and morbidity from HIV, transforming the disease into a chronic medical condition where newly diagnosed individuals can expect to live a near-normal life expectancy. When choosing therapy, probably the most important considerat...

    journal_title:Expert review of anti-infective therapy

    pub_type: 杂志文章,评审

    doi:10.1586/eri.11.125

    authors: Scourfield A,Waters L,Nelson M

    更新日期:2011-11-01 00:00:00

  • Procalcitonin-guided antibiotic therapy for chronic obstructive pulmonary disease exacerbations.

    abstract::The aim of this article is to review the current literature examining the use of procalcitonin-guided antibiotic therapy for management of chronic obstructive pulmonary disease (COPD) exacerbations. Procalcitonin is a serum marker that rises in response to bacterial infections, but remains low in nonbacterial infectio...

    journal_title:Expert review of anti-infective therapy

    pub_type: 杂志文章,评审

    doi:10.1586/eri.11.45

    authors: Tokman S,Schuetz P,Bent S

    更新日期:2011-06-01 00:00:00

  • Itraconazole (Sporanox) in superficial and systemic fungal infections.

    abstract::Itraconazole (Sporanox) is a triazole antifungal agent with a broad activity spectrum and favorable pharmacokinetic and safety profiles. Numerous clinical trials have established the efficacy and safety of itraconazole in the treatment of superficial fungal infections. In this field, full exploitation of its pharmacok...

    journal_title:Expert review of anti-infective therapy

    pub_type: 杂志文章,评审

    doi:10.1586/14787210.1.4.531

    authors: Caputo R

    更新日期:2003-12-01 00:00:00

  • Antimicrobial resistance and the management of anaerobic infections.

    abstract::Management of anaerobic infections encompasses surgical procedures, antibacterial therapy and adjuncts. At present, metronidazole, penems, beta-lactam/beta-lactamase inhibitor combinations and chloramphenicol have the highest activity against obligate anaerobes. Tigecycline is a promising new agent. Other antibacteria...

    journal_title:Expert review of anti-infective therapy

    pub_type: 杂志文章,评审

    doi:10.1586/14787210.5.4.685

    authors: Boyanova L,Kolarov R,Mitov I

    更新日期:2007-08-01 00:00:00

  • Pegylated IFN-alpha2a and ribavirin in the treatment of hepatitis C.

    abstract::Chronic hepatitis C is a major worldwide health problem with an estimated prevalence of 1.6-2%. The prognosis of chronic hepatitis C depends on the rate of fibrosis progression which, over a 20-30-year time span, may determine the risk of developing cirrhosis and its complications, namely hepatocellular carcinoma, liv...

    journal_title:Expert review of anti-infective therapy

    pub_type: 杂志文章,评审

    doi:10.1586/eri.09.70

    authors: Aghemo A,Rumi MG,Colombo M

    更新日期:2009-10-01 00:00:00

  • Immune approaches in tuberculosis therapy: a brief overview.

    abstract::TB is typically caused by Mycobacterium tuberculosis, a symbiotic bacterium present in one-third of the world's population. There any many factors triggering overt clinical disease in a small proportion of humans. In our view the major role in the process is played by the host's immune response, especially self-direct...

    journal_title:Expert review of anti-infective therapy

    pub_type: 杂志文章,评审

    doi:10.1586/eri.12.1

    authors: Bourinbaiar AS,Mezentseva MV,Butov DA,Nyasulu PS,Efremenko YV,Jirathitikal V,Mishchenko VV,Kutsyna GA

    更新日期:2012-03-01 00:00:00

  • Strategies for the eradication of extended-spectrum beta-lactamase or carbapenemase-producing Enterobacteriaceae intestinal carriage.

    abstract::Introduction: Among the multidrug resistant pathogens, extended-spectrum beta-lactamase (ESBL-E) or carbapenemase-producing Enterobacteriaceae (CPE) are currently considered the main threat due to the scarcity of therapeutic options and their rapid spread around the globe. In addition to developing new antibiotics and...

    journal_title:Expert review of anti-infective therapy

    pub_type: 杂志文章,评审

    doi:10.1080/14787210.2019.1645007

    authors: Catho G,Huttner BD

    更新日期:2019-08-01 00:00:00

  • Telaprevir for the treatment of chronic hepatitis C infection.

    abstract::Telaprevir is an NS3/4A protease inhibitor that has recently received US FDA approval for the treatment of chronic HCV infection. Telaprevir is given in combination with peg-IFN-α and ribavirin and is indicated for both treatment-naive and treatment-experienced patients with genotype 1 infection. Along with the other ...

    journal_title:Expert review of anti-infective therapy

    pub_type: 杂志文章,评审

    doi:10.1586/eri.11.133

    authors: Muir AJ

    更新日期:2011-12-01 00:00:00

  • Treatment of neurocysticercosis: is it beneficial?

    abstract::Neurocysticercosis is the most common parasitic disease of the CNS. Intracranial neurocysticercosis is classified into cerebral parenchymal and extraparenchymal forms (subarachnoidal and intraventricular). Current medical therapy for parenchymal and extraparenchymal neurocysticercosis invovles the use of anticysticerc...

    journal_title:Expert review of anti-infective therapy

    pub_type: 杂志文章

    doi:10.1586/14787210.6.4.435

    authors: Garg RK

    更新日期:2008-08-01 00:00:00

  • Ceftobiprole: drug evaluation and place in therapy.

    abstract::Introduction: Ceftobiprole is a fifth-generation cephalosporin with a broad spectrum of antimicrobial activity, including also methicillin-resistant Staphylococcus aureus (MRSA). Ceftobiprole is approved for the treatment of community-acquired pneumonia (CAP) and hospital-acquired pneumonia (HAP), excluding ventilator...

    journal_title:Expert review of anti-infective therapy

    pub_type: 杂志文章,评审

    doi:10.1080/14787210.2019.1667229

    authors: Giacobbe DR,De Rosa FG,Del Bono V,Grossi PA,Pea F,Petrosillo N,Rossolini GM,Tascini C,Tumbarello M,Viale P,Bassetti M

    更新日期:2019-09-01 00:00:00

  • Antibiotic resistance rates in causative agents of infections in diabetic patients: rising concerns.

    abstract::The vicious cycle is that hyperglycemia (≥11.1 mmol/l) or other diabetes-associated factors facilitate or worsen the development of infections and vice versa, the infections deteriorate the glycemic control of the patients. Diabetic patients are prone to some infections, infection recurrences and poor outcomes. Immuno...

    journal_title:Expert review of anti-infective therapy

    pub_type: 杂志文章,评审

    doi:10.1586/eri.13.19

    authors: Boyanova L,Mitov I

    更新日期:2013-04-01 00:00:00

  • Fixed dose combination abacavir/lamivudine in the treatment of HIV-1 infection.

    abstract::The fixed dose combination of abacavir with lamivudine represents a new treatment option for patients infected with HIV. Fixed dose combination abacavir/lamivudine has the convenience of one pill and once-daily dosing. It achieves comparable suppression of plasma HIV RNA with the pill's individual components dosed twi...

    journal_title:Expert review of anti-infective therapy

    pub_type: 杂志文章,评审

    doi:10.1586/14787210.3.6.871

    authors: Anderson AM,Bartlett JA

    更新日期:2005-12-01 00:00:00

  • Influenza and other respiratory viruses: standardizing disease severity in surveillance and clinical trials.

    abstract:INTRODUCTION:Influenza-Like Illness is a leading cause of hospitalization in children. Disease burden due to influenza and other respiratory viral infections is reported on a population level, but clinical scores measuring individual changes in disease severity are urgently needed. Areas covered: We present a composite...

    journal_title:Expert review of anti-infective therapy

    pub_type: 杂志文章,评审

    doi:10.1080/14787210.2017.1295847

    authors: Rath B,Conrad T,Myles P,Alchikh M,Ma X,Hoppe C,Tief F,Chen X,Obermeier P,Kisler B,Schweiger B

    更新日期:2017-06-01 00:00:00